Cite
HARVARD Citation
Gajjar, A. et al. (2021). Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03). Journal of clinical oncology. 39 (7), pp. 822-835. [Online].